BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4282384)

  • 1. Relationship of biogenic amines to behavior.
    Breese GR; Cooper BR; Hollister AS
    J Psychiatr Res; 1974; 11():125-33. PubMed ID: 4282384
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate.
    Breese GR; Cooper BR; Hollister AS
    Psychopharmacologia; 1975 Oct; 44(1):5-10. PubMed ID: 128026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced brain monoamine depletion and its behavioral correlates in Caiman sclerops.
    Doshi E; Huggins SE
    Comp Biochem Physiol C Comp Pharmacol; 1977; 57(2):153-7. PubMed ID: 20272
    [No Abstract]   [Full Text] [Related]  

  • 8. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments.
    Cooper BR; Cott JM; Breese GR
    Psychopharmacologia; 1974 Jul; 37(3):235-48. PubMed ID: 4851731
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract]   [Full Text] [Related]  

  • 12. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of changes in brain monoamine metabolism on behaviour of herpes simplex-infected mice.
    Lycke E; Roos BE
    J Neurol Sci; 1974 Jul; 22(3):277-89. PubMed ID: 4151982
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 16. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 17. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
    Lima L; Sourkes TL
    Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain.
    Marsden CA; Guldberg HC
    Neuropharmacology; 1973 Mar; 12(3):195-211. PubMed ID: 4266877
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of the influence of 6-hydroxydopamine, alpha methyltyrosine and 5,6-dihydroxy-tryptamine, p-chlorophenylalanine on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC; Jain KM
    Indian J Physiol Pharmacol; 1974; 18(4):324-9. PubMed ID: 4282853
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting the activity of 5-HT-containing neurones.
    Bramwell GJ
    Brain Res; 1974 Oct; 79(3):515-9. PubMed ID: 4278895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.